★
AZTA
Azenta Inc · Life Sciences Tools & Services
FCF$30mC-
Rev-5.9%D
D/E0.03A
P/S1.8xA-
PEG——
67Score
$22.891Y Target$30.90Near-term target
5Y Target$46.04Compound horizon
10Y Target$119.80Long-dated conviction
FCF$30mTTM · 03/26C-
FCF $30m — barely positive; fragile cash position · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev-5.9%TTM YoYD
Revenue -5.9% — meaningful contraction · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.03totalA
D/E 0.03 — essentially debt-free, pristine balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S1.8xA-
P/S 1.8x — cheap for any tech/growth name
PEG—proxy—
PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Life Sciences Tools & Services · market cap $1.1b. Down 45% from 52-week high of $41.73 — deep drawdown territory. Revenue -6% — in contraction; any catalyst that reverses this triggers re-rating.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Revenue contracting -6% — the operational turn is not yet visible in the top line. Currently unprofitable (margin -29.9%) — path to GAAP profitability is the core thesis risk. Down 45% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $30.90 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $46.04 — requires the platform / technology to reach commercial scale. 10 yr $119.80 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · AZTA
Shares to buy
87
Position size
$1,991
4.0% of portfolio
Stop price
$17.17
25% below $22.89
$ at risk
$500.00
1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.